Epigenetic plasticity and the hallmarks of cancer

Flavahan, William A., Gaskell, Elizabeth, Bernstein, Bradley E.·2017·Science

Cited by (1,001)

Items 101–200 of 1,001

  1. BRD4 promotes gastric cancer progression and metastasis through acetylation-dependent stabilization of Snail
    Qin, Zhong-yi, Wang, Tao, Su, Siyuan, Shen, Li-ting, Zhu, Guang-xi, Liu, Qin, Zhang, Liang, Liu, Ke-wei, Zhang, Yue, Zhou, Zhi-hua et al. · 2019 · Cancer Research
  2. Cancer Stem Cells: From Historical Roots to a New Perspective
    Jean‐Pascal Capp · 2019 · Journal of Oncology
  3. Stimuli-responsive nanocarriers for delivery of bone therapeutics – Barriers and progresses
    Pedro Lavrador, Vítor M. Gaspar, João Filipe Mano · 2018 · Journal of Controlled Release
  4. Loss and revival of androgen receptor signaling in advanced prostate cancer
    Nicolò Formaggio, Mark A. Rubin, Jean-Philippe Paul. Theurillat · 2021 · Oncogene
  5. Epigenetics of aging and disease: a brief overview
    Christina Pagiatakis, Elettra Musolino, Rosalba Gornati, Giovanni Bernardini, Roberto Papait · 2019 · Aging Clinical and Experimental Research
  6. Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg
    Fernández-Barrena, Maite G., Arechederra, María, Colyn, Leticia, Berasain, Carmen, Avila, Matias A. · 2020 · JHEP Reports
  7. Nuclear Mechanopathology and Cancer Diagnosis
    Caroline Uhler, G. V. Shivashankar · 2018 · Trends in cancer
  8. Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis
    Yun Zhang, Joana Liu Donaher, Sunny Das, Xin Li, Ferenc Reinhardt, Jordan A. Krall, Arthur W. Lambert, Prathapan Thiru, Heather R. Keys, Mehreen Khan et al. · 2022 · Nature Cell Biology
  9. The role of molecular modelling and simulation in the discovery and deployment of metal-organic frameworks for gas storage and separation
    Árni Sturluson, Melanie T. Huynh, Alec R. Kaija, Caleb Laird, Sunghyun Yoon, Feier Hou, Zhenxing Feng, Christopher E. Wilmer, Yamil J. Colón, Yongchul G. Chung et al. · 2019 · Molecular Simulation
  10. Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
    Vera Miranda‐Gonçalves, Ana Lameirinhas, Rui Henrique, Cármen Jerónimo · 2018 · Frontiers in Genetics
  11. Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling
    Junlong Zhao, Huichen Li, Shoujie Zhao, Enxin Wang, Jun Wei Zhu, Dayun Feng, Yejing Zhu, Weijia Dou, Qingling Fan, Jie Hu et al. · 2021 · Molecular Cancer
  12. NSD2 is a conserved driver of metastatic prostate cancer progression
    Àlvaro Aytés, Arianna Giacobbe, Antonina Mitrofanova, Katia Ruggero, Joanna Cyrta, Juan Martín Arriaga, Luís Palomero, Sònia Farran-Matas, Mark A. Rubin, Michael M. Shen et al. · 2018 · Nature Communications
  13. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy
    Dorota Natalia Komar, Przemysław Juszczyński · 2020 · Clinical Epigenetics
  14. The function and mechanism of lactate and lactylation in tumor metabolism and microenvironment
    Yan Zhang, Qiu Peng, Jinhua Zheng, Yuzhong Yang, Xuemei Zhang, Aiyu Ma, Yuxia Qin, Zailong Qin, Zheng Xiang · 2022 · Genes & Diseases
  15. Reprogramming the epigenome with vitamin C
    Lee Chong, Taylor, Ahearn, Emily L., Cimmino, Luisa · 2019 · Frontiers in Cell and Developmental Biology
  16. The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma
    Vivek Bhaskaran, Michal Oskar Nowicki, M. Bennani-Baiti Idriss, Miguel A. Jiménez, Gianmarco Lugli, Josie L. Hayes, Ahmad Bakur Mahmoud, Rachel Zane, Carmela Passaro, Keith Lloyd Ligon et al. · 2019 · Nature Communications
  17. Histone lactylation regulates cancer progression by reshaping the tumor microenvironment
    Junxing Qu, Peizhi Li, Zhiheng Sun · 2023 · Frontiers in Immunology
  18. The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them
    Martyn T. Smith, Kathryn Z. Guyton, Nicole Kleinstreuer, Alexandre Borrel, Andrés Cárdenas, Weihsueh A. Chiu, Dean W. Felsher, Catherine F. Gibbons, William H. Goodson, Keith A. Houck et al. · 2020 · Cancer Epidemiology Biomarkers & Prevention
  19. Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin
    Martina Tedesco, Francesca Giannese, Dejan Lazarević, Valentina Giansanti, Dalia Rosano, Silvia Monzani, Irene Catalano, Elena Grassi, Eugenia Rosalinda Zanella, Oronza Antonietta Botrugno et al. · 2021 · Nature Biotechnology
  20. Genome-wide profiling in colorectal cancer identifies PHF19 and TBC1D16 as oncogenic super enhancers
    Qinglan Li, Xiang Lin, Yali Yu, Lin Chen, Qi‐Xin Hu, Meng Chen, Nan Cao, Chen Zhao, Chen-Yu Wang, Cheng‐Wei Huang et al. · 2021 · Nature Communications
  21. Protein phase separation and its role in tumorigenesis
    Shan Jiang, Johan Bourghardt Fagman, Changyan Chen, Simon Alberti, Beidong Liu · 2020 · eLife
  22. Origins of human disease: the chrono-epigenetic perspective
    Oh, Edward Saehong, Petronis, Art · 2021 · Nature Reviews Genetics
  23. Blueprint for cancer research: Critical gaps and opportunities
    Lynne W. Elmore, Susanna Fletcher Greer, Elvan C. Daniels, Charles C. Saxe, Michael H. Melner, Ginger M. Krawiec, William G. Cance, William C. Phelps · 2020 · CA A Cancer Journal for Clinicians
  24. Neuroblastoma and the epigenome
    Irfete Sh. Fetahu, Sabine Taschner‐Mandl · 2021 · Cancer and Metastasis Reviews
  25. Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential
    Joo‐Hyung Lee, Feng Xiong, Wenbo Li · 2020 · RNA Biology
  26. LTR retroelement expansion of the human cancer transcriptome and immunopeptidome revealed by de novo transcript assembly
    Jan Attig, George R. Young, Louise Hosie, David Perkins, Vesela Encheva-Yokoya, Jonathan P. Stoye, Ambrosius P. Snijders, Nicola Ternette, George Kassiotis · 2019 · Genome Research
  27. MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer
    Mohammad Mijanur Rahman, Andrew C. Brane, Trygve O. Tollefsbol · 2019 · Cells
  28. Intratumoral heterogeneity and drug resistance in cancer
    Yue-Chun Fu, Shao-Bo Liang, Min Luo, Xue‐Ping Wang · 2025 · Cancer Cell International
  29. LSD1/KDM1A, a Gate-Keeper of Cancer Stemness and a Promising Therapeutic Target
    Panagiotis Karakaidos, John Verigos, Angeliki Magklara · 2019 · Cancers
  30. Genetic and epigenetic determinants of diffuse large B-cell lymphoma
    Tanner J. Bakhshi, Philippe T. Georgel · 2020 · Blood Cancer Journal
  31. Profiling the genetic determinants of chromatin accessibility with scalable single-cell CRISPR screens
    Liscovitch-Brauer, Noa, Montalbano, Antonino, Deng, Jiale, Méndez-Mancilla, Alejandro, Wessels, Hans-Hermann, Moss, Nicholas G., Kung, Chia-Yu, Sookdeo, Akash, Guo, Xinyi, Geller, Evan et al. · 2021 · Nature Biotechnology
  32. CBX2 Regulates Proliferation and Apoptosis via the Phosphorylation of YAP in Hepatocellular Carcinoma
    Jiakai Mao, Yu Tian, Chengye Wang, Keqiu Jiang, Rui Li, Yifan Yao, Rixin Zhang, Deguang Sun, Rui Liang, Zhenming Gao et al. · 2019 · Journal of Cancer
  33. Epigenetic mechanisms and the hallmarks of cancer: an intimate affair.
    Nadine Darwiche · 2020 · PubMed Central
  34. Novel biomarkers for early detection of gastric cancer
    Tasuku Matsuoka, Masakazu Yashiro · 2023 · World Journal of Gastroenterology
  35. Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
    Xueting Xia, Zongxin Yang, Qisi Lu, Zhenyun Liu, Lei Wang, Jinwen Du, Yuhua Li, Dong‐Hua Yang, Shaojie Wu · 2024 · Molecular Cancer
  36. Epigenetic aberrations in human pluripotent stem cells
    Shiran Bar, Nissim Benvenisty · 2019 · The EMBO Journal
  37. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin
    Liang, Wen-Wei, Lu, Rita Jui-Hsien, Jayasinghe, Reyka G., Foltz, Steven M., Porta-Pardo, Eduard, Geffen, Yifat, Wendl, Michael C., Lazcano, Rossana, Kolodziejczak, Iga, Song, Yizhe et al. · 2023 · Cancer Cell
  38. Epigenetic modifiers as new immunomodulatory therapies in solid tumours
    Sandrine Aspeslagh, Daphné Morel, Jean‐Charles Soria, Sophie C. Postel-Vinay · 2018 · Annals of Oncology
  39. The chromatin basis of neurodevelopmental disorders: Rethinking dysfunction along the molecular and temporal axes
    Gabriele, Michele, Lopez Tobon, Alejandro, D'Agostino, Giuseppe, Testa, Giuseppe · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  40. Combinatorial strategies to target RAS-driven cancers
    Naiara Perurena, Lisa Situ, Karen M. Cichowski · 2024 · Nature reviews. Cancer
  41. Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP/TAZ
    Giulia Della Chiara, Federica Gervasoni, Michaela Fakiola, Chiara Godano, Claudia D’Oria, Luca Azzolin, Raoul J.P. Bonnal, Giulia Moreni, Lorenzo Drufuca, Grazisa Rossetti et al. · 2021 · Nature Communications
  42. The Innovative Potential of Statins in Cancer: New Targets for New Therapies
    Di Bello, Elisabetta, Zwergel, Clemens, Mai, Antonello, Valente, Sergio · 2020 · Frontiers in Chemistry
  43. Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas
    Xin Hu, Marcos R. Estecio, Runzhe Chen, Alexandre Reuben, Linghua Wang, Junya Fujimoto, Jian Carrot‐Zhang, Nicholas McGranahan, Lisha Ying, Junya Fukuoka et al. · 2021 · Nature Communications
  44. Lactate and lactylation: Behind the development of tumors
    Enci Dai, Wei Wang, Yingying Li, Defeng Ye, Yanli Li · 2024 · Cancer Letters
  45. KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition
    Yuanwang Pan, Han Han, Hai Hu, Hua Wang, Yueqiang Song, Hao Yuan, Xinyuan Tong, Ayushi S. Patel, Seli̇m Misirlioğlu, Sittinon Tang et al. · 2022 · Cancer Cell
  46. Integrative pan cancer analysis reveals epigenomic variation in cancer type and cell specific chromatin domains
    Lijin K. Gopi, Benjamin L. Kidder · 2021 · Nature Communications
  47. The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy
    Helen Loo Yau, Ilias Ettayebi, Daniel Diniz De Carvalho · 2018 · Trends in Cell Biology
  48. A developmental constraint model of cancer cell states and tumor heterogeneity
    Ayushi S. Patel, Itai Yanai · 2024 · Cell
  49. USP9X-mediated KDM4C deubiquitination promotes lung cancer radioresistance by epigenetically inducing TGF-β2 transcription
    Xiaohua Jie, William Pat Fong, Rui Zhou, Ye Zhao, Yingchao Zhao, Rui Meng, Sheng Zhang, Xiaorong Dong, Tao� Zhang, Kunyu Yang et al. · 2021 · Cell Death and Differentiation
  50. Analysis of chromatin accessibility uncovers TEAD1 as a regulator of migration in human glioblastoma
    Jessica Tomé-García, Parsa Erfani, German Nudelman, Alexander M. Tsankov, Igor Katsyv, Rut Tejero, Bin Zhang, Martin J. Walsh, Roland H. Friedel, Elena Zaslavsky et al. · 2018 · Nature Communications
  51. Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer
    Yufeng Ding, Ni Li, Baijun Dong, Wangxin Guo, Hui Wei, Qilong Chen, Huairui Yuan, Ying Han, Hanwen Chang, Shan Kan et al. · 2018 · Journal of Clinical Investigation
  52. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm
    Zichang Yang, Quan Zi, Kang Xu, Chunli Wang, Qingjia Chi · 2020 · International Immunopharmacology
  53. Molecular Engineering of Plasma Membrane and Mitochondria Dual‐Targeted NIR‐II AIE Photosensitizer Evoking Synergetic Pyroptosis and Apoptosis
    Jiabao Zhuang, Zhedong Ma, Nan Li, Huan Chen, Lijin Yang, Ying Lü, Keyi Guo, Na Zhao, Ben Zhong Tang · 2023 · Advanced Materials
  54. HDAC inhibitors as epigenetic regulators for cancer immunotherapy
    Mariarosaria Conte, Raffaele De Palma, Lucia Altucci · 2018 · The International Journal of Biochemistry & Cell Biology
  55. 5-Hydroxymethylome in Circulating Cell-Free DNA as A Potential Biomarker for Non-Small-Cell Lung Cancer
    Ji Zhang, Xiao Han, Chun‐Chun Gao, Yurong Xing, Qi Zheng, Ruijuan Liu, Yueqin Wang, Xiaojian Zhang, Yun‐Gui Yang, Xiangnan Li et al. · 2018 · Genomics Proteomics & Bioinformatics
  56. Illuminating the noncoding genome in cancer
    Xiaoyang Zhang, Matthew M. Meyerson · 2020 · Nature Cancer
  57. Trials and tribulations of pancreatic cancer immunotherapy
    Daniel R. Principe, Murray Korc, Suneel Deepak Kamath, Hidayatullah G. Munshi, Ajay Rana · 2021 · Cancer Letters
  58. Cisplatin Resistance: Genetic and Epigenetic Factors Involved
    Yuliannis Lugones, Pía Loren, Luis Antonio Salazar · 2022 · Biomolecules
  59. Epigenetic and Transcriptional Variability Shape Phenotypic Plasticity
    Simone Ecker, Véra Pancaldi, Alfonso Valencia, Stephan Beck, Dirk S. Paul · 2017 · BioEssays
  60. Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL
    Alessandro Pastore, Federico Gaiti, Sydney X. Lu, Ryan M. Brand, Scott Kulm, Ronan Chaligné, Hongcang Gu, Kevin Y. Huang, Elena K. Stamenova, Wendy Béguelin et al. · 2019 · Nature Communications
  61. KRAB-ZFP Transcriptional Regulators Acting as Oncogenes and Tumor Suppressors: An Overview
    Joanna Sobocińska, Sara Molenda, Marta Machnik, Urszula Oleksiewicz · 2021 · International Journal of Molecular Sciences
  62. Heritable transcriptional defects from aberrations of nuclear architecture
    Stamatis Papathanasiou, Nikos A. Mynhier, Shiwei Liu, Gregory J. Brunette, Ema Stokasimov, Etai Jacob, Lanting Li, Caroline Comenho, Bas van Steensel, Jason D. Buenrostro et al. · 2023 · Nature
  63. Meiosis-like Functions in Oncogenesis: A New View of Cancer
    Ramsay J. McFarlane, Jane A. Wakeman · 2017 · Cancer Research
  64. The microcosmos of intratumor heterogeneity: the space-time of cancer evolution
    Michalina Janiszewska · 2019 · Oncogene
  65. mSWI/SNF promotes Polycomb repression both directly and through genome-wide redistribution
    Christopher M. Weber, Antonina Hafner, Jacob G. Kirkland, Simon M. G. Braun, Benjamin Z. Stanton, Alistair Nicol Boettiger, Gerald R. Crabtree · 2021 · Nature Structural & Molecular Biology
  66. HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity
    Dimitris Karagiannis, Theodoros N Rampias · 2021 · Cancers
  67. Epigenomic heterogeneity as a source of tumour evolution
    Marthe Laisné, Mathieu Lupien, Céline Vallot · 2024 · Nature reviews. Cancer
  68. The duality of human oncoproteins: drivers of cancer and congenital disorders
    Pau Castel, Katherine A. Rauen, Frank P. McCormick · 2020 · Nature reviews. Cancer
  69. Deregulation of Retroelements as an Emerging Therapeutic Opportunity in Cancer
    Charles A. Ishak, Marie Classon, Daniel Diniz De Carvalho · 2018 · Trends in cancer
  70. Reconstructing the molecular life history of gliomas
    Floris P Barthel, Pieter Wesseling, Roel G.W. Verhaak · 2018 · Acta Neuropathologica
  71. Signaling to and from the RNA Polymerase III Transcription and Processing Machinery
    Ian M. Willis, Robyn D. Moir · 2018 · Annual Review of Biochemistry
  72. The Mitochondrial Citrate Carrier (SLC25A1) Sustains Redox Homeostasis and Mitochondrial Metabolism Supporting Radioresistance of Cancer Cells With Tolerance to Cycling Severe Hypoxia
    Julian Hlouschek, Christine Hansel, Verena Jendrossek, Johann Matschke · 2018 · Frontiers in Oncology
  73. Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2
    Lei Zhou, Changsheng Yang, Ning Zhang, Xin Zhang, Tingbao Zhao, Jinming Yu · 2020 · Biomedicine & Pharmacotherapy
  74. Making Sense of the Epigenome Using Data Integration Approaches
    Emma Cazaly, Joseph J Saad, Wenyu Wang, Caroline Akemi Heckman, Miina Ollikainen, Jing Ping Tang · 2019 · Frontiers in Pharmacology
  75. Lamina Associated Domains and Gene Regulation in Development and Cancer
    Silke J. A. Lochs, Samy Kefalopoulou, Jop Kind · 2019 · Cells
  76. Natural variation in DNA methylation homeostasis and the emergence of epialleles
    Yinwen Zhang, Jered M. Wendte, Lexiang Ji, Robert J. Schmitz · 2020 · Proceedings of the National Academy of Sciences
  77. Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets
    Tiansu Wang, Allison R. Pine, Andriana G. Kotini, Han Yuan, Lee Zamparo, Daniel T. Starczynowski, Christina S. Leslie, Eirini P. Papapetrou · 2021 · Cell stem cell
  78. Metabolic determinants of tumour initiation
    Julia S. Brunner, Lydia W.S. Finley · 2022 · Nature Reviews Endocrinology
  79. Epigenetic regulation in lung cancer
    Shahin Ramazi, Maedeh Dadzadi, Zahra Sahafnejad, Abdollah Allahverdi · 2023 · MedComm
  80. KDM6A epigenetically regulates subtype plasticity in small cell lung cancer
    Leslie Duplaquet, Yixiang Li, Matthew Aaron Booker, Yingtian Xie, Sarah Naomi Olsen, Radhika A. Patel, Deli Hong, Charlie Hatton, Thomas Denize, Emily Walton et al. · 2023 · Nature Cell Biology
  81. Gain-of-Function Genetic Alterations of G9a Drive Oncogenesis
    Shinichiro Kato, Qing Yu Weng, Megan L. Insco, Kevin Y. Chen, Sathya Muralidhar, Joanna Poźniak, Joey Mark S. Diaz, Yotam Drier, Nathalie T. Nguyen, Jennifer A. Lo et al. · 2020 · Cancer Discovery
  82. Engineering in Medicine To Address the Challenge of Cancer Drug Resistance: From Micro- and Nanotechnologies to Computational and Mathematical Modeling
    Morgan Craig, Adrianne L. Jenner, Bumseok Namgung, Luke P. Lee, Aaron J. Goldman · 2020 · Chemical Reviews
  83. Mapping Phenotypic Plasticity upon the Cancer Cell State Landscape Using Manifold Learning
    Daniel B. Burkhardt, Beatriz P. San Juan, John George Lock, Smita Krishnaswamy, Christine Louise Chaffer · 2022 · Cancer Discovery
  84. Antitumor Drugs and Their Targets
    Zlatko Dembić · 2020 · Molecules
  85. Current paradigms in epigenetic anticancer therapeutics and future challenges
    Manoj Pratap Singh, Vikas Kumar, Nirmala Sehrawat, Mukesh Kumar Yadav, Mayank Chaudhary, Sushil Kumar Upadhyay, Sunil Kumar, Varruchi Sharma, Sandeep Kumar, Neeraj Dilbaghi et al. · 2021 · Seminars in Cancer Biology
  86. Modeling epigenetic lesions that cause gliomas
    Gilbert J. Rahme, Nauman M. Javed, Kaitlyn L. Puorro, Shouhui Xin, Volker Hovestadt, Sarah E. Johnstone, B Bernstein · 2023 · Cell
  87. Epigenomes in Cardiovascular Disease
    Manuel Rosa‐Garrido, Douglas J. Chapski, Thomas M. Vondriska · 2018 · Circulation Research
  88. Modification of miRNA Expression through plant extracts and compounds against breast cancer: Mechanism and translational significance
    Fayyaz Ahmed, Bushra Ijaz, Zarnab Ahmad, Nadia Farooq, Muhammad Bilal Sarwar, Tayyab Husnaın · 2020 · Phytomedicine
  89. Epigenetic regulation of tumor immunity
    Lizhi Pang, Fei Zhou, Yang Liu, Heba A. Ali, Fatima Khan, Amy B. Heimberger, Peiwen Chen · 2024 · Journal of Clinical Investigation
  90. Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma
    Xiang Wang, Chunliang Liu, Jianan Chen, Lei Chen, Xianwen Ren, Minghui Hou, Xiuliang Cui, Youhai Jiang, Erdong Liu, Yali Zong et al. · 2022 · Cell Discovery
  91. Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules
    Chen Chen, Xiaojie Huang, Wei Yin, Muyun Peng, Fang Wu, Xia Wu, Jingqun Tang, Mingjiu Chen, Xiang Wang, Alicia Hulbert et al. · 2020 · Clinical Epigenetics
  92. Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancer
    Sarah M. Groves, Geena V. Ildefonso, Caitlin O. McAtee, Patricia Midori Murobushi Ozawa, Abbie S. Ireland, Philip E. Stauffer, Perry T. Wasdin, Xiaomeng Huang, Yi Qiao, Jing Shan Lim et al. · 2022 · Cell Systems
  93. Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation
    Pratyusha Bala, Jonathan P. Rennhack, Daulet Aitymbayev, Clare X. Morris, Sydney M. Moyer, Gina N. Duronio, Khoa Tat Doan, Zhixin Li, Xiaoyan Liang, Jason L. Hornick et al. · 2023 · Science Advances
  94. LSD1 Inhibition Promotes Epithelial Differentiation through Derepression of Fate-Determining Transcription Factors
    Shaun Egolf, Yann Aubert, Miriam Doepner, Amy Anderson, Alexandra M. Maldonado López, Gina Pacella, Jessica Lee, Eun Kyung Ko, Jonathan Zou, Yemin Lan et al. · 2019 · Cell Reports
  95. A novel cell‐free DNA methylation‐based model improves the early detection of colorectal cancer
    Xianrui Wu, Yunfeng Zhang, Tuo Hu, Xiaowen He, Yifeng Zou, Qiling Deng, Jia Ke, Lei Lian, Xiaosheng He, Dezhi Zhao et al. · 2021 · Molecular Oncology
  96. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis
    Siming Qu, Li Jin, Hanfei Huang, Jie Lin, Weiwu Gao, Zhong Zeng · 2021 · BMC Cancer
  97. Impact of epigenetic reprogramming on antitumor immune responses in glioma
    Brandon L. McClellan, Santiago Haase, Felipe Javier Núñez, Mahmoud S. Alghamri, Ali A. Dabaja, Pedro Ricardo Lowenstein, Maria Graciela Castro · 2023 · Journal of Clinical Investigation
  98. Intratumor heterogeneity in epigenetic patterns
    Yassen Assenov, David Brocks, Clarissa Gerhäuser · 2018 · Seminars in Cancer Biology
  99. Aberrant activation of m6A demethylase FTO renders HIF2α low/− clear cell renal cell carcinoma sensitive to BRD9 inhibitors
    Chuanjie Zhang, Lu Chen, Weijuan Lou, JunHui Su, Jingyi Huang, Ao Liu, Yang Xu, Hongchao He, Yi Gao, Danfeng Xu et al. · 2021 · Science Translational Medicine
  100. The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics
    Hong‐Yi Lin, Ah‐Jung Jeon, Kaina Chen, Chang Jie Mick Lee, Lingyan Wu, Shay-Lee Chong, Chukwuemeka George Anene-Nzelu, Roger Foo, Pierce K. H. Chow · 2025 · British Journal of Cancer